Stock Comparison

LXRX vs AAPL

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricLXRXLexicon Pharmaceuticals, Inc.AAPLApple Inc.
Market Cap$436.08M$3.84T
Current Price$1.20$261.05
P/E Ratio-1.9034.99
Revenue Growth 1Y24.8%6.4%
Net Margin-6.4%26.9%
ROE-167.7%171.4%
ROIC-81.1%70.6%
Debt/Equity0.741.34
FCF Yield2.6%
Dividend Yield0.4%
Loading chart...

LXRX vs AAPL: Key Questions Answered

Which stock is growing the fastest: LXRX or AAPL?

Lexicon Pharmaceuticals, Inc. (LXRX) is growing the fastest with 24.8% revenue growth. Apple Inc. has the slowest growth at 6.4%. Higher growth often justifies higher valuations.

Which has the best profit margins: LXRX or AAPL?

Apple Inc. (AAPL) has the strongest profitability with a 26.9% net margin. Lexicon Pharmaceuticals, Inc. has the lowest at -6.4%. Higher margins indicate pricing power and efficiency.

Which is the largest company: LXRX or AAPL?

Apple Inc. (AAPL) is the largest company with a market cap of $3.84T. Lexicon Pharmaceuticals, Inc. is the smallest at $0.4B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: LXRX or AAPL?

Apple Inc. (AAPL) generates the best returns on shareholder equity with an ROE of 1.7%. Lexicon Pharmaceuticals, Inc. has the lowest at -1.7%. Higher ROE indicates efficient use of capital.